MW
Manojkumar Wasudevrao Nandanwar
About Manojkumar Wasudevrao Nandanwar
Data last updated:
Manojkumar Wasudevrao Nandanwar has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Fresh Hilites Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Fresh Hilites Medicaments Private Limited at ₹22.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Oct 2020 | 2020 | ₹22.18 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manojkumar Wasudevrao Nandanwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manojkumar Wasudevrao Nandanwar
Manojkumar Wasudevrao Nandanwar has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Fresh Hilites Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Fresh Hilites Medicaments Private Limited at ₹22.18 Cr (FY 2025).
Manojkumar Wasudevrao Nandanwar is associated with 1 company as Director, including Fresh Hilites Medicaments Private Limited (₹22.18 Cr).
Manojkumar Wasudevrao Nandanwar has expertise in General Business.
Manojkumar Wasudevrao Nandanwar has 6 years in corporate governance.
By reported revenue, the largest current company of Manojkumar Wasudevrao Nandanwar is Fresh Hilites Medicaments Private Limited, with revenue of ₹22.18 Cr (FY 2025).
Manojkumar Wasudevrao Nandanwar currently holds positions at 1 company: Fresh Hilites Medicaments Private Limited (₹22.18 Cr).